Ticker
INMBCompany Name
INMUNE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 37.68M | $ 50K | 0.13% |
3/31/2025 | $ 37.8M | $ 50K | 0.13% |
12/31/2024 | $ 39.56M | $ 14K | 0.04% |
9/30/2024 | $ 52.78M | $ 42K | 0.08% |
6/30/2024 | $ 52.45M | $ 85K | 0.16% |
3/31/2024 | $ 46.83M | $ 131K | 0.28% |
12/31/2023 | $ 57M | $ 155K | 0.27% |
9/30/2023 | $ 62.7M | $ 224K | 0.36% |
6/30/2023 | $ 69.72M | $ 279K | 0.4% |
3/31/2023 | $ 73.98M | $ 249K | 0.34% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for INMUNE BIO INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 42.82M ]
(=) GPA [ 0% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 84.08% |
average | 20.16% |
median | 15.34% |
std | 19.94% |